Company / Free Cash Flow per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.03
FY2025
5-year range
$0.22 / $1.03
FY2021-FY2025
Trend
+52.0%
vs FY2024
Sector context
#47 of 192
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's free cash flow per share of $1.03 is higher than 76% of companies in the Health Care sector (FY2025). Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $1.03.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of +10.4%. Top quartile in the Health Care sector.
Improved from $0.76 to $1.03 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
-69.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 52.0% year-over-year.
- Ranks #47 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | +52.0% |
| FY2024 | $0.67 | -11.3% |
| FY2023 | $0.76 | -20.1% |
| FY2022 | $0.95 | +339.9% |
| FY2021 | $0.22 | -65.4% |
| FY2020 | $0.62 | +184.7% |
| FY2019 | $0.22 | -100.0% |
| FY2018 | $1867845.99 | +140468555.0% |
| FY2017 | $1.33 | -100.0% |
| FY2016 | $3110301.77 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026